Lindemann K, Berton D, Sehouli J, Christensen RD, et al. NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer. Gynecol Oncol 2025;199:79-87.
PMID: 40592025